SHAWN KHAN: Open Payments
NPI 1649828096 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$816 in 21 payments from 8 companies in 2025. Trend: 2023 $715 · 2024 $388 · 2025 $816
Food & beverage: $717Education: $99
| Company | Payments | Amount |
|---|---|---|
| Optinose US, Inc. | 5 | $212 |
| Regeneron Healthcare Solutions, Inc. | 5 | $197 |
| Integra LifeSciences Corporation | 1 | $107 |
| GENZYME CORPORATION | 4 | $101 |
| GlaxoSmithKline, LLC. | 2 | $80 |
| Smith+Nephew, Inc. | 1 | $59 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $42 |
| Lilly USA, LLC | 1 | $19 |
Products named: DUPIXENT, Xhance, ACCLARENT AERA, NUCALA, TULA, NEFFY, ZEPBOUND.
Industry payments across AZ — which companies pay providers there.
